Western Digital, the Western Digital design, and the Western Digital logo ... Neck Cancer and in Combination with WELIREG® (belzutifan) in Renal Cell Carcinoma Exelixis, Inc. and Merck , known ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Gilead Sciences said on Friday it was voluntarily withdrawing the U.S. approval for Trodelvy in previously treated patients ...

The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

We recently compiled a list of 10 Most Promising Long-Term Stocks According to Hedge Funds. In this article, we will look at ...

Keytruda succeeds n a Phase 3 trial for head and neck cancer, showing promising results for event-free survival, the study's ...

Merck also changed the outlook for its Healthcare business to "slight growth", compared to a previously expected ...

German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...

Merck's Keytruda (pembrolizumab) met primary endpoint of event-free survival (EFS) in Phase 3 trial for newly diagnosed head ...